1. Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma

   • Adam J. Bograd
   • Kei Suzuki
   • Prasad S. Adusumilli

   Review 13 September 2011 Pages: 1509 - 1527

   

2. Dual biological effects of the cytokines interleukin-10 and interferon-γ

   • Cailin Moira Wilke
   • Shuang Wei
   • Weiping Zou

   Opinion Paper 15 September 2011 Pages: 1529 - 1541

3. Priming with very low-affinity peptide ligands gives rise to CD8⁺ T-cell effectors with enhanced function but with greater susceptibility to transforming growth factor (TGF)β-mediated suppression

   • Jeremy A. O’Sullivan
   • Andrew Zloza
   • José A. Guevara-Patiño

   Original article 17 June 2011 Pages: 1543 - 1551

   

4. Vaccination of patients with cutaneous melanoma with telomerase-specific peptides

   • Robert E. Hunger
   • Kristin Kernland Lang
   • Gustav Gaudernack

   Original article 17 June 2011 Pages: 1553 - 1564

   

5. Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide

   • Mitsuru Sakakibara
   • Tatsuya Kanto
   • Norio Hayashi

   Original article 17 June 2011 Pages: 1565 - 1575

   

6. Prostaglandin E₂ (PGE₂) suppresses natural killer cell function primarily through the PGE₂ receptor EP4

   • Dawn Holt
   • Xinrong Ma
   • Amy Fulton

   Original article 17 June 2011 Pages: 1577 - 1586

   

7. Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietin

   • Hui Li
   • Hua Zhao
   • Xiubao Ren

   Original Article 17 June 2011 Pages: 1587 - 1596

   

8. Vaccination with CD133⁺ melanoma induces specific Th17 and Th1 cell–mediated antitumor reactivity against parental tumor

   • Takao Miyabayashi
   • Hiroshi Kagamu
   • Ichiei Narita

   Original Article 21 June 2011 Pages: 1597 - 1608

   

9. Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation

   • Edit Kovalcsik
   • Katie Lowe
   • Mark D. Bodman-Smith

   Original article 21 June 2011 Pages: 1609 - 1624

   

10. Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™

    • Theo Nicholaou
    • Weisan Chen
    • Jonathan Cebon

    Original article 23 June 2011 Pages: 1625 - 1637

    

11. Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer

    • Riccardo Turrini
    • Anna Merlo
    • Antonio Rosato

    Short communication Open access 11 August 2011 Pages: 1639 - 1645

    

12. “Tumor immunology meets oncology (TIMO) VII” from 15th to 16th of April 2011 in Halle/Saale, Germany

    • Juergen Bukur
    • Elfriede Noessner
    • Barbara Seliger

    Meeting report 11 September 2011 Pages: 1647 - 1653